OBJECTIVE: To examine the effect of continuous subcutaneous insulin infusion (CSII)
therapy on parameters affecting long-term outcome in type 1 diabetes. STUDY DESIGN …

Objective. The purpose of this study was to determine the feasibility of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in routine pediatric diabetes care …

Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased
dramatically in recent years, and pump therapy has been shown to be a safe and effective …

Objective: The aim of this study was to investigate the safety and efficacy of continuous
subcutaneous insulin infusion (CSII) for type 1 diabetes mellitus (T1DM) in toddlers and …

Aims To determine the safety and effectiveness of continuous subcutaneous insulin infusion
(CSII) in attaining long‐term glycaemic control in paediatric patients with Type 1 diabetes …

Aim: To evaluate blood glucose and HbAu levels, insulin dosage, hypoglycemia rate and
body mass index (BMI) at baseline, and at 3 and 6 months after initiation of continuous …

Objective. To compare the efficacy and feasibility of continuous subcutaneous insulin
infusion (CSII) with multiple daily insulin injections (MDI) in children with type 1 diabetes …

The incidence of type 1 diabetes mellitus (T1DM) in young children has increased
considerably over recent years. The purpose was to examine the effectiveness and safety of …

Background: There are currently few data available on the long-term use of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in children. Methods: Charts from …

Objective: To compare medical, nutritional, and psychosocial outcomes of continuous
subcutaneous insulin infusion (CSII) therapy and multiple daily insulin injections (MDI) in …